Analysis of sleep disorders under pain using an optogenetic tool: Possible involvement of the activation of dorsal raphe nucleus-serotonergic neurons

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Ito, Hisakatsu ^a,b   Yanase, Makoto ^a   Yamashita, Akira ^a   Kitabatake, Chigusa ^a   Hamada, Asami ^a   Suhara, Yuki ^a   Narita, Michiko ^a   Ikegami, Daigo ^a   Sakai, Hiroyasu ^a   Yamazaki, Mitsuaki ^b   Narita, Minoru ^a,b  

^a HOSHI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Dorsal raphe nucleus; Electroencephalogram; Neuropathic pain; Optogenetics; Sleep

Indexed keywords

FLUOROGOLD; SEROTONIN;

ALERTNESS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; ARTICLE; CELL LABELING; CHRONIC PAIN; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ELECTROENCEPHALOGRAM; ELECTROSTIMULATION; HYPERALGESIA; IMMUNOREACTIVITY; LOSS OF FUNCTION MUTATION; MALE; MICROINJECTION; MOUSE; NERVE CELL STIMULATION; NEUROPATHIC PAIN; NONHUMAN; NONREM SLEEP; OPTOGENETICS; PHOTOSTIMULATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REM SLEEP; SCIATIC NERVE; SEROTONINERGIC NERVE CELL; SLEEP DISORDER; WAKEFULNESS;

MUS;

ANIMALS; DIALYSIS; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; HYPERALGESIA; LIGATION; MICE; MICROINJECTIONS; NEURALGIA; OPTOGENETICS; PREFRONTAL CORTEX; RAPHE NUCLEI; SCIATIC NERVE; SEROTONERGIC NEURONS; SLEEP; SLEEP DISORDERS; STILBAMIDINES; TRANSGENES; WAKEFULNESS;

EID: 84890926376     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-59     Document Type: Article

References (59)

1. Sleep quality and presleep arousal in chronic pain. Smith MT, Perlis ML, Smith MS, Giles DE, Carmody TP, J Behav Med 2000 23 1 1 13 10.1023/A: 1005444719169 10749008 (Pubitemid 30164132)
2. Self-reported sleep and mood disturbance in chronic pain patients. Morin CM, Gibson D, Wade J, Clin J Pain 1998 14 4 311 314 10.1097/00002508-199812000- 00007 9874009 (Pubitemid 28560153)
3. The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Jouvet M, Ergeb Physiol 1972 64 166 307 4403272
4. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Trulson ME, Jacobs BL, Brain Res 1979 163 1 135 150 10.1016/0006-8993(79)90157-4 218676 (Pubitemid 9111292)
5. Single unit recordings in the nuclei raphe dorsalis and magnus during the sleep-waking cycle of semi-chronic prepared cats. Cespuglio R, Faradji H, Gomez ME, Jouvet M, Neurosci Lett 1981 24 2 133 138 10.1016/0304-3940(81)90236-6 7254710 (Pubitemid 11054931)
6. Serotonin neurons and sleep. II. Time course of dorsal raphe discharge, PGO waves, and behavioral states. Lydic R, McCarley RW, Hobson JA, Arch Ital Biol 1987 126 1 1 28 3449005
7. Dorsal raphe neurons: depression of firing during sleep in cats. McGinty DJ, Harper RM, Brain Res 1976 101 3 569 575 10.1016/0006-8993(76)90480-7 1244990
8. Release of endogenous serotonin from "encephale isole" cats. II-Correlations with raphe neuronal activity and sleep and wakefulness. Puizillout JJ, Gaudin-Chazal G, Daszuta A, Seyfritz N, Ternaux JP, J Physiol Paris 1979 75 5 531 537 533869 (Pubitemid 10241315)
9. Sleep-waking discharge profiles of dorsal raphe nucleus neurons in mice. Sakai K, Neuroscience 2011 197 200 224 21958868
10. Differential effects of noxious and non-noxious input on neurones according to location in ventral periaqueductal grey or dorsal raphe nucleus. Sanders KH, Klein CE, Mayor TE, Heym C, Handwerker HO, Brain Res 1980 186 1 83 97 10.1016/0006-8993(80)90257-7 7357452 (Pubitemid 10131863)
11. Functional activity mapping of the rat brainstem during formalin-induced noxious stimulation. Porro CA, Cavazzuti M, Galetti A, Sassatelli L, Neuroscience 1991 41 2-3 667 680 1870704
12. C-fos expression during electroacupuncture analgesia in rats-an immunohistochemical study. Dai JL, Zhu YH, Li XY, Huang DK, Xu SF, Acupunct Electrother Res 1992 17 3 165 176 1357923
13. Differential adaptive changes on serotonin and noradrenaline transporters in a rat model of peripheral neuropathic pain. Rojo ML, Rodriguez-Gaztelumendi A, Pazos A, Diaz A, Neurosci Lett 2012 515 2 181 186 10.1016/j.neulet.2012.03. 050 22480692
14. Optogenetics. Deisseroth K, Nat Methods 2011 8 1 26 29 21191368
15. Next-generation optical technologies for illuminating genetically targeted brain circuits. Deisseroth K, Feng G, Majewska AK, Miesenbock G, Ting A, Schnitzer MJ, J Neurosci 2006 26 41 10380 10386 10.1523/JNEUROSCI.3863-06. 2006 17035522 (Pubitemid 44564588)
16. Cell type-specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Zhao S, Ting JT, Atallah HE, Qiu L, Tan J, Gloss B, Augustine GJ, Deisseroth K, Luo M, Graybiel AM, et al. Nat Methods 2011 8 9 745 752 10.1038/nmeth.1668 21985008
17. Millisecond-timescale, genetically targeted optical control of neural activity. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K, Nat Neurosci 2005 8 9 1263 1268 10.1038/nn1525 16116447 (Pubitemid 43348147)
18. Optogenetics in neural systems. Yizhar O, Fenno LE, Davidson TJ, Mogri M, Deisseroth K, Neuron 2011 71 1 9 34 10.1016/j.neuron.2011.06.004 21745635
19. The development and application of optogenetics. Fenno L, Yizhar O, Deisseroth K, Annu Rev Neurosci 2011 34 389 412 10.1146/annurev-neuro-061010- 113817 21692661
20. The microbial opsin family of optogenetic tools. Zhang F, Vierock J, Yizhar O, Fenno LE, Tsunoda S, Kianianmomeni A, Prigge M, Berndt A, Cushman J, Polle J, et al. Cell 2011 147 7 1446 1457 10.1016/j.cell.2011.12.004 22196724
21. An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. Aravanis AM, Wang LP, Zhang F, Meltzer LA, Mogri MZ, Schneider MB, Deisseroth K, J Neural Eng 2007 4 3 143 S156 10.1088/1741-2560/4/3/S02 17873414
22. Optogenetic manipulation of neural circuitry in vivo. Kravitz AV, Kreitzer AC, Curr Opin Neurobiol 2011 21 3 433 439 10.1016/j.conb.2011.02.010 21420852
23. Remote control of behavior through genetically targeted photostimulation of neurons. Lima SQ, Miesenbock G, Cell 2005 121 1 141 152 10.1016/j.cell.2005. 02.004 15820685
24. Sleep patterns over 21-day period in rats with chronic constriction of sciatic nerve. Andersen ML, Tufik S, Brain Res 2003 984 1-2 84 92 12932842 (Pubitemid 36976797)
25. Changes in forebrain serotonin at the light-dark transition: correlation with behaviour. Rueter LE, Jacobs BL, Neuroreport 1996 7 5 1107 1111 10.1097/00001756-199604100-00031 8804061 (Pubitemid 26194490)
26. Distribution and quantification of 5-HT nerve cell bodies in the nucleus raphe dorsalis area of C57BL and BALBc mice. Relationship between anatomy and biochemistry. Daszuta A, Portalier P, Brain Res 1985 360 1-2 58 64 3000536 (Pubitemid 16171001)
27. Quantitative analysis of the distribution of serotonin-immunoreactive cell bodies in the mouse brain. Ishimura K, Takeuchi Y, Fujiwara K, Tominaga M, Yoshioka H, Sawada T, Neurosci Lett 1988 91 3 265 270 10.1016/0304-3940(88) 90691-X 3185964
28. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. Vertes RP, J Comp Neurol 1991 313 4 643 668 10.1002/cne.903130409 1783685
29. Mechanism of the EEG-synchronizing action of serotonin. Koella WP, Czicman J, Am J Physiol 1966 211 4 926 934 5926579
30. Does para-chlorophenylalanine produce disturbed waking, disturbed sleep or activation by ponto-geniculo-occipital waves in cats? Ursin R, Waking Sleeping 1980 4 3 211 221 6456599 (Pubitemid 11111979)
31. Differential effect of para-chlorophenylalanine on the two slow wave sleep stages in the cat. Ursin R, Acta Physiol Scand 1972 86 2 278 285 10.1111/j.1748-1716.1972.tb05333.x 4344858
32. Effect of cooling and electrical stimulation of nuclei of raphe system on states of alertness in cat. Cespuglio R, Gomez ME, Walker E, Jouvet M, Electroencephalogr Clin Neurophysiol 1979 47 3 289 308 10.1016/0013-4694(79) 90281-5 90600 (Pubitemid 9224405)
33. Cooling of the nucleus raphe dorsalis induces sleep in the cat. Cespuglio R, Walker E, Gomez ME, Musolino R, Neurosci Lett 1976 3 4 221 227 10.1016/0304-3940(76)90077-X 19604890 (Pubitemid 8013237)
34. Sleep-related neurons in the central nucleus of the amygdala of rats and their modulation by the dorsal raphe nucleus. Jha SK, Ross RJ, Morrison AR, Physiol Behav 2005 86 4 415 426 10.1016/j.physbeh.2005.06.033 16137725 (Pubitemid 41586236)
35. Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat. Portas CM, Thakkar M, Rainnie D, McCarley RW, J Neurosci 1996 16 8 2820 2828 8786456 (Pubitemid 26124354)
36. Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat. Monti JM, Jantos H, Eur J Pharmacol 2003 478 2-3 121 130 14575796 (Pubitemid 37315730)
37. Effect of tryptamine and tryptamine homologues on cerebral electrical activity and behaviour in the cat. Bradley PB, Marley E, Br J Pharmacol Chemother 1965 24 659 674 10.1111/j.1476-5381.1965.tb01622.x 14340920
38. Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat. Adrien J, Tissier MH, Lanfumey L, Haj-Dahmane S, Jolas T, Franc B, Hamon M, Neuropharmacology 1992 31 6 519 529 10.1016/0028-3908(92)90183-P 1407392
39. Optogenetic investigation of neural circuits underlying brain disease in animal models. Tye KM, Deisseroth K, Nat Rev Neurosci 2012 13 4 251 266 10.1038/nrn3171 22430017
40. Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Portas CM, Bjorvatn B, Ursin R, Prog Neurobiol 2000 60 1 13 35 10.1016/S0301-0082(98)00097-5 10622375 (Pubitemid 30001450)
41. Activity of brain serotonergic neurons in the behaving animal. Jacobs BL, Fornal CA, Pharmacol Rev 1991 43 4 563 578 1775508
42. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Adell A, Celada P, Abellan MT, Artigas F, Brain Res Brain Res Rev 2002 39 2-3 154 180 12423765 (Pubitemid 35341097)
43. Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: relevance for neuropharmacological therapy. Lechin F, van der Dijs B, Hernandez-Adrian G, Prog Neuropsychopharmacol Biol Psychiatry 2006 30 4 565 585 10.1016/j.pnpbp.2005.11.025 16436311
44. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. Boutrel B, Franc B, Hen R, Hamon M, Adrien J, J Neurosci 1999 19 8 3204 3212 10191333 (Pubitemid 29174012)
45. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice. Boutrel B, Monaca C, Hen R, Hamon M, Adrien J, J Neurosci 2002 22 11 4686 4692 12040075 (Pubitemid 37465683)
46. Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor. Frank MG, Stryker MP, Tecott LH, Neuropsychopharmacology 2002 27 5 869 873 10.1016/S0893-133X(02)00353-6 12431861 (Pubitemid 35335903)
47. Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. Popa D, Lena C, Fabre V, Prenat C, Gingrich J, Escourrou P, Hamon M, Adrien J, J Neurosci 2005 25 49 11231 11238 10.1523/JNEUROSCI.1724-05.2005 16339018 (Pubitemid 43083697)
48. 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG, Biol Psychiatry 2005 58 10 831 837 10.1016/j.biopsych.2005.05.012 16018977 (Pubitemid 41677422)
49. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat. Monti JM, Jantos H, Eur J Pharmacol 2006 553 1-3 163 170 17059817 (Pubitemid 44794499)
50. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat. Monti JM, Jantos H, Lagos P, Behav Brain Res 2010 206 1 8 16 10.1016/j.bbr.2009.08.037 19737581
51. Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635. Monti JM, Jantos H, Monti D, Eur Neuropsychopharmacol 2002 12 1 47 55 10.1016/S0924-977X(01)00133-X 11788240 (Pubitemid 34098830)
52. Effects of the selective 5-HT1B agonist, CGS 12066B, on sleep/waking stages and EEG power spectrum in rats. Bjorvatn B, Ursin R, J Sleep Res 1994 3 2 97 105 10.1111/j.1365-2869.1994.tb00112.x 10607113
53. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Berridge CW, Waterhouse BD, Brain Res Brain Res Rev 2003 42 1 33 84 10.1016/S0165-0173(03)00143-7 12668290 (Pubitemid 36369264)
54. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS, J Neurosci 2002 22 17 7695 7711 12196593 (Pubitemid 35386369)
55. Acetylcholine systems and rhythmic activities during the waking-sleep cycle. Steriade M, Prog Brain Res 2004 145 179 196 14650916 (Pubitemid 37442944)
56. Activity profiles of cholinergic and intermingled GABAergic and putative glutamatergic neurons in the pontomesencephalic tegmentum of urethane-anesthetized rats. Boucetta S, Jones BE, J Neurosci 2009 29 14 4664 4674 10.1523/JNEUROSCI.5502-08.2009 19357291
57. Discharge profiles of identified GABAergic in comparison to cholinergic and putative glutamatergic basal forebrain neurons across the sleep-wake cycle. Hassani OK, Lee MG, Henny P, Jones BE, J Neurosci 2009 29 38 11828 11840 10.1523/JNEUROSCI.1259-09.2009 19776269
58. Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Malmberg AB, Chen C, Tonegawa S, Basbaum AI, Science 1997 278 5336 279 283 10.1126/science.278.5336.279 9323205 (Pubitemid 27450873)
59. Franklin K, Paxinos G, The Mouse Brain in Stereotaxic Coordinates San Diego: Academic 2007